Asthma/Rhinitis + IgE Total Package
The "Asthma/Rhinitis, Adults + IgE (Total)" package is a comprehensive analysis designed to detect sensitization to common indoor allergens (such as D. pteronyssinus dust mites), epidermal allergens (cat and dog dander), and pollen allergens (silver birch, timothy grass, mugwort, ragweed), which may contribute to the development and/or exacerbation of allergic rhinitis (including rhinoconjunctivitis) and bronchial asthma. The goal of this package is to facilitate rational elimination and treatment strategies for these conditions.
According to the World Health Organization (WHO), approximately 40% of the global population suffers from allergies, with 12-45% of these individuals being affected by allergic rhinitis.
Allergic rhinitis is a condition characterized by a range of symptoms, including a runny nose with nasal congestion, sneezing, itching, rhinorrhea, and nasal mucosal swelling. It is a common condition that significantly impacts the quality of life.
Bronchial asthma is a respiratory disease characterized by bronchial hyperreactivity, airway narrowing, and episodes of breathlessness. Both men and women are equally affected by asthma. Asthma and rhinitis often start in childhood or adulthood.
According to recommendations from the European Academy of Allergy and Clinical Immunology (EAACI), testing for allergy to dust mites, cats, dogs, trees, and grasses is advised for adults with asthma or rhinitis in European countries.
The goal of this package is to determine specific IgE levels to key household, epidermal, and pollen allergens using the ImmunoCAP method. Allergy testing using ImmunoCAP is known for its high accuracy and specificity, as it can detect even low concentrations of specific IgE in small blood samples. The World Health Organization and the World Allergy Organization recognize ImmunoCAP as the "gold standard" in allergy diagnostics, as this method has demonstrated accuracy and result stability in independent studies.
The "Asthma/Rhinitis, Adults" package also includes the measurement of total Immunoglobulin E (IgE) using the ImmunoCAP method, which allows for a detailed assessment of overall allergen sensitivity and enables comparison of specific IgE to total IgE levels. This provides a more complete picture of the causal allergen profile